Panos E. Vasiloudes MD, PhD, FAAD, FAAP, FASMS
Panos Vasiloudes, MD, PhD, holds a dual board certification in dermatology and pediatrics and is a highly skilled MOHS surgeon. Dr. V has obtained his PhD in the area of cell and molecular biology. As a native of Cyprus, he attended medical school at the Philipps University in Marburg, Germany where he obtained his degree in 1987. Subsequently, he performed research at the renowned Rockefeller University in New York and Philipps University in Marburg, before completing his training in Europe at the University of Freiburg.
Dr. Vasiloudes was awarded his PhD summa cum laude in 1989, after publishing his research in numerous peer-reviewed publications. He completed an accredited pediatric residency at Hahnemann University Hospital, Philadelphia in 1993 and a second accredited residency in dermatology at the University of Colorado Health Sciences Center in 1998.
Dr. Vasiloudes is board certified by the American Board of Dermatology and the American Board of Pediatrics. He is a member and fellow of numerous local, national and international professional organizations. A fellow of the American Academy of Dermatology, American Academy of Pediatrics and the American Society of Mohs Surgery, Dr. V has been practicing medical and surgical as well as aesthetic and cosmetic dermatology in the greater Tampa Bay Area for many years. He also teaches dermatology at USF as a volunteer assistant professor, where he has a dual appointment with the departments of dermatology and pediatrics.
Fluent in Greek, German and English, Dr. Vasiloudes uniquely incorporates classical world values with old world education and expresses them in a very unique American way.
Panos Vasiloudes In The News
Get to know Academic Alliance In Dermatology’s CEO and President, Dr. Panos Vasiloudes. He discusses his initial reason for beginning his journey in pediatric and clinical dermatology and his passion for all of his patients ranging from newborns to elderly patients.
Dr. Panos Vasiloudes was featured on Bloomberg TV in January 2019 to discuss what Melanoma is, how he identifies this form of skin cancer in patients, and how he effectively treats this Melanoma to ensure quality care for each of his patients.